Cargando…
Insights for COVID-19 in 2023
Predictions for a near end of the pandemic by the World Health Organization should be interpreted with caution. Current evidence indicates that the efficacy of a fourth dose of classical mRNA vaccines (BT162b2 or mRNA-1273) is low and short-lived in preventing SARS-CoV-2 infection in its predominant...
Autores principales: | Sánchez, Francisco Javier Martín, Martínez-Sellés, Manuel, García, José María Molero, Guillén, Santiago Moreno, Rodríguez-Artalejo, Fernando, Ruiz-Galiana, Julián, Cantón, Rafael, Ramos, Pilar De Lucas, García-Botella, Alejandra, García-Lledó, Alberto, Hernández-Sampelayo, Teresa, Gómez-Pavón, Javier, del Castillo, Juan González, Martín-Delgado, Mari Cruz, Bouza, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066911/ https://www.ncbi.nlm.nih.gov/pubmed/36510683 http://dx.doi.org/10.37201/req/122.2022 |
Ejemplares similares
-
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
por: García, José María Molero, et al.
Publicado: (2023) -
Vacunación anti-COVID-19: La realidad tras los ensayos clínicos
por: Ruiz-Galiana, Julián, et al.
Publicado: (2021) -
New variants of SARS-CoV-2
por: Cantón, Rafael, et al.
Publicado: (2021) -
Pharmacological treatment of COVID-19: an opinion paper
por: García-Lledó, Alberto, et al.
Publicado: (2021) -
Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)